Latest papers

Genotyping of Madurella mycetomatis by selective amplification of restriction fragments (amplified fragment length polymorphism) and subtype correlation with geographical origin and lesion size.

[Clinical cases in medical mycology. Case No. 19].

Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method.

A case of eumycetoma due to Madurella grisea in northern Brazil.

Mycetoma caused by Madurella mycetomatis: a neglected infectious burden.

In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay.

Eumycetoma due to Madurella grisea--a case report.

Serum immunoglobulins and IgG subclass levels in sinus mycetoma

Phylogeny and typification of Madurella mycetomatis, with a comparison of other agents of eumycetoma.

A rice isoflavone reductase-like gene, OsIRL, is induced by rice blast fungal elicitor.

Madurella mycetomatis strains from mycetoma lesions in Sudanese patients are clonal.

Isolation and identification of Madurella mycetomatis from two cases of black grain mycetoma in Libya.

Branched filaments no fungus, ovoid bodies no bacteria: two unusual cases of mycetoma

A murine model of Madurella mycetomatis eumycetoma.

[Mycetoma of the hand].

Mycetoma in Yemen: clinicoepidemiologic and histopathologic study.

Environmental occurrence of Madurella mycetomatis, the major agent of human eumycetoma in Sudan.

Madura foot in the U.K.: fungal osteomyelitis after renal transplantation.

A unique case of bladder mycetoma.

Eumycetoma due to Madurella mycetomatis acquired in Jamaica.